Short communication · 6 Jun 2018
Conference abstract
Data analytics in Pharmacovigilance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmacovigilance (PV) is one of the most critical activities of any pharmaceutical organization. From the perspective of data analytics - Pharmacovigilance is a storehouse of actionable insights. If we could apply data analytics in a meaningful way to PV data -we would definitely generate highly actionable insights. We have PV Case data on one hand and PV Organization, operational data at the other. We could utilize both types of data to an organization?s maximum benefit. PV Case data could be mined for Signal Detection and PV organizational data could be analyzed to achieve operational efficiencies. ?Signal detection is the act of looking for and/or identifying signals using event data from any source?. Spontaneous Reporting Systems (SRSs) constitute the dominant source of signals through which suspected cases are voluntarily reported by healthcare professionals (and lately patients) to regulatory authorities and other bodies. Prominent SRSs are the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS1) of US, EudraVigilance maintained by the European Medicines Agency and VigiBase3 maintained by the Uppsala Monitoring Center of the World Health Organization (WHO-UMC). PV Data Analytics could be done through any of the following tools depending upon the skill set of the user - Excel, VBA Macros, R, SAS, SAS JMP, and Tableau etc. Different sorts of Visual Dashboards could be prepared. The data sources could be - Company Internal Data, FDA AERS Data etc. Data Mining could also be done on safety databases like ARGUS Safety Database. Data Analytics could very well be applied on Social Media data. Mining of Adverse Event data from social media has its own set of problems for e.g. problem of structured vs unstructured data, the validity of data, intentions and data aggregation. Thus, PV Data analytics / visual analytics could provide us meaningful inferences which could be used to deduce highly actionable insights. These actionable insights may lead to increased operational and performance efficiencies.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 29 Nov 2025
Pharmacovigilance: Modern Safety, Real- World Data, AI
Article · 24 Dec 2024
Extracting Clinical Insights from Pharmacovigilance Data: Identifying Drug Interactions and Population-Specific Risks
Conference abstract · 28 Aug 2024
Real-world safety data of the orphan drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA rare disease: a pharmacovigilance study based on the EMA adverse event reporting system
Article · 29 Mar 2024
Leveraging Big Data and Machine Learning to Enhance Pharmacovigilance Signal Detection
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Advancing Patient Safety Through Modern Pharmacovigilance Practices
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Amit Srivastava”

